key: cord-0943471-d7gs0zd3
authors: A., Ciccullo; A., Borghetti; L., Zileri Dal Verme; A., Tosoni; F., Lombardi; M., Garcovich; F., Biscetti; M., Montalto; R., Cauda; S., Di Giambenedetto
title: Neutrophil-to-lymphocyte ratio and clinical outcome in COVID-19: a report from the Italian front line.
date: 2020-05-11
journal: Int J Antimicrob Agents
DOI: 10.1016/j.ijantimicag.2020.106017
sha: 57b73838e8e9ba5e8ffd94879460c2cd344af703
doc_id: 943471
cord_uid: d7gs0zd3

• Clinicians are looking for a reliable prognostic marker for patients with COVID-19; • In our cohort, clinical improvement was predicted by younger age and a NLR below 3; • Transfer to ICU was instead predicted by a NLR over 4 (p=0.046); • NLR is a fast, widely available and relatively inexpensive assessment; • NLR may be a useful tool in the early screening of patients with COVID-19.

Dear Editor, since December 2019, cases of SARS-CoV-2-related disease, now known as COVID-19, have rapidly spread from the Hubei province of China to the whole world. The World Health Organization (WHO) has officially recognised COVID-19 as a pandemic and Countries worldwide are now facing huge challenges trying to further prevent its spread and treating the growing number of positive patients. In fact, although the majority of cases are usually self-limiting with mild symptoms such as low-grade fever and cough, the diseases can be deadly [1] . Serious cases of COVID-19 can develop severe pneumonia, acute respiratory distress syndrome (ARDS) and multiple organ failures leading to death; the mortality rate is much higher in elder patients with pre-existing chronic diseases [1] . Clinicians are searching for a reliable prognostic marker that can distinguish patients at risk of developing more severe forms of disease, in order to better manage hospital resources. The Neutrophil-to-Lymphocyte Ratio (NLR) in peripheral blood has been studied as a systemic inflammatory marker and various works have shown that it is a valid prognostic factor in various solid tumors [3] and other chronic diseases, such as lung, cardiovascular and kidney diseases. In our work we described the clinical characteristics of hospitalized patients with COVID-19 and aimed to assess predictors of clinical outcomes.

We retrospectively analyzed a group of 74 patients with confirmed COVID-19 hospitalized in our center in March 2020. Patients' follow-up was censored on March 28th 2020. COVID-19 diagnosis was performed via molecular assay from nasopharyngeal and oropharyngeal swabs. For each patient, demographic data, clinical history, laboratory findings and treatment measures during hospitalization were collected.

According to sign, symptoms, comorbidities and clinical parameters at admission and during hospitalization, patients were divided into severe and non-severe cases, in accordance with Italian guidelines [3] . Clinical improvement was defined as the resolution of fever for at least 48 hours and the suspension of oxygen supplementation. We used parametric and non-parametric tests, as appropriate, to compare changes; logistic regression analyses were used to assess predictors.

We analyzed 74 patients: 51 (68.9%) were males, with median age of 63 years (Interquartile Range [IQR] 52-73) and a median time between symptoms onset and hospitalization of 7 days (IQR [3] [4] [5] [6] [7] [8] [9] At a multivariate analysis, clinical improvement was predicted by a younger age (p=0.040) and a NLR below 3 (p=0.010), after adjusting for sex, pre-existing hypertension and signs of interstitial pneumonia at admission. Transfer to ICU was instead predicted by a NLR over 4 (p=0.046), after adjusting for age. Death was solely predicted by an older age (p=0.047), after adjusting for NLR, sex, pre-existing hypertension and signs of interstitial pneumonia at hospital admission.

COVID-19 is a rapidly spreading infectious disease, caused by SARS-CoV-2, a novel coronavirus. In recent weeks, reports on the feasibility of either NLR or PLR in predicting prognosis in patients with SARS-CoV-2 infection have been published. In particular, a work by Qu et al [4] hypothesized a possible prognostic role of PLR by analyzing the data of a cohort of 30 patients with confirmed COVID-19. A recent work by Qin et al [5] , meanwhile, showed a significant higher NLR in patients with severe forms of COVID-19, in a cohort of severe outcome: in particular, a NLR over 4 resulted predictor of transfer to the ICU. Patients with severe disease, presented a significantly higher NLR at admission compared with patients with milder form of COVID-19, a result in line with the work of Qin et al [5] , reinforcing the theory of a close association between hyperinflammatory state and COVID-19 pathogenesys.

Although further studies, with a larger sample size, will be needed to properly assess the matter, our study shows that NLR may be a fast, widely available, useful prognostic factor in the early screening of critical illness in patients with confirmed COVID-19.

None.

All authors declare no competing interests.

Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study

Prognostic role of neutrophil-to-lymphocyte ratio in solid tumors: a systematic review and meta-analysis

Vademecum per la cura delle persone con malattia da COVI-19 Edizione 2.0

Dysregulation of immune response in patients with COVID-19 in

Ethical Approval: The work was approved by local Ethics Commitee, protocol number 15892/20